Anja Kathrin Wege (Anja K Wege)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Breast Cancer Cells

Epidermal Growth Factor Receptor

Top Venues

International journal of molecular sciences

Journal of translational medicine

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Veruschka Albert, Christina Bruss, Deniz Tümen, Gerhard Piendl, Florian Weber, Edgar Dahl, Stephan Seitz, Olaf Ortmann, Anja Kathrin Wege, Gero Brockhoff
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice. International journal of molecular sciences 25 (13) (2024)
Veruschka Albert, Christina Bruss, Deniz Tümen, Gerhard Piendl, Florian Weber, Edgar Dahl, Stephan Seitz, Olaf Ortmann, Anja Kathrin Wege, Gero Brockhoff
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice. International journal of molecular sciences 25 (13) (2024)
Christina Bruss, Kerstin Kellner, Veruschka Albert, James A Hutchinson, Stephan Seitz, Olaf Ortmann, Gero Brockhoff, Anja Kathrin Wege
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion. Cancers 15 (9) (2023)
Christina Bruss, Kerstin Kellner, Veruschka Albert, James A Hutchinson, Stephan Seitz, Olaf Ortmann, Gero Brockhoff, Anja Kathrin Wege
Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion. Cancers 15 (9) (2023)
Christina Bruss, Kerstin Kellner, Olaf Ortmann, Stephan Seitz, Gero Brockhoff, James A Hutchinson, Anja Kathrin Wege
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice. Cancers 14 (9) (2022)
Anja Kathrin Wege, Tobias F Dreyer, Attila Teoman, Olaf Ortmann, Gero Brockhoff, Holger Bronger
CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM). Cancers 13 (10) (2021)
Tobias F Dreyer, Sabine Kuhn, Christoph Stange, Nadine Heithorst, Daniela Schilling, Jil Jelsma, Wolfgang Sievert, Stefanie Seitz, Stefan Stangl, Alexander Hapfelmeier, Aurelia Noske, Anja Kathrin Wege, Wilko Weichert, Juergen Ruland, Manfred Schmitt, Julia Dorn, Marion Kiechle, Ute Reuning, Viktor Magdolen, Gabriele Multhoff, Holger Bronger
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In Vivo. Cancer immunology research 9 (7) (2021)
Daniela Schulz, Martin Wetzel, Jonas Eichberger, Gerhard Piendl, Gero Brockhoff, Anja Kathrin Wege, Torsten E Reichert, Tobias Ettl, Richard J Bauer
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 22 (23) (2021)
Anja Kathrin Wege, Nicole Kirchhammer, Linda Veronique Kazandjian, Sandra Prassl, Michael Brandt, Gerhard Piendl, Olaf Ortmann, Stephan Fischer, Gero Brockhoff
A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM). Journal of translational medicine 18 (1) (2020)
Anja Kathrin Wege
Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (3) (2018)
Paloma Riquelme, Jan Haarer, Anja Kammler, Lisa Walter, Stefan Tomiuk, Norbert Ahrens, Anja Kathrin Wege, Ivan Goecze, Daniel Zecher, Bernhard Banas, Rainer Spang, Fred Fändrich, Manfred B Lutz, Birgit Sawitzki, Hans Jürgen Schlitt, Jordi Ochando, Edward K Geissler, James A Hutchinson
TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity. Nature communications 9 (1) (2018)